Vicente Alfaro

Years Active: 2020-2021
Publications (10 Years): 3

PharmaMar SA

Universitat de Barcelona (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

PharmaMar SA

Spain

Medical Writer Manager :: Clinical R&D

Universitat de Barcelona

Spain

Associate Professor :: Physiology, School of Biology

Education History

Universitat de Barcelona

Spain

MSC :: Immunology

Universitat de Barcelona

Spain

PHD :: Physiology

Publications

Javier Baena, Andrea Modrego, Ali Zeaiter, Carmen Kahatt, Vicente Alfaro, Elizabeth Jimenez-Aguilar, Jose María Mazarico, Luis Paz-Ares
Lurbinectedin in the treatment of relapsed small cell lung cancer. Future oncology (London, England) 17 (18) (2021)
Rebecca Kristeleit, Victor Moreno, Valentina Boni, Eva M Guerra, Carmen Kahatt, Ignacio Romero, Emiliano Calvo, Neus Basté, José A López-Vilariño, Mariano Siguero, Vicente Alfaro, Ali Zeaiter, Martin Forster
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31 (11) (2021)
Salvador Fudio, Josep Tabernero, Vivek Subbiah, Sant P Chawla, Victor Moreno, Federico Longo, Rafael Lopez, Antonio Anton, Jose Manuel Trigo, Geoffrey Shapiro, Woondong Jeong, Victor Manuel Villalobos, Rubin Lubomirov, Carlos Fernández-Teruel, Vicente Alfaro, Valentina Boni
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis. Cancer chemotherapy and pharmacology 87 (1) (2020)

Vicente Alfaro.css-eqlu8i{font-size:small;padding-left:4px;}